Year: 2026
Type: article
Abstract: Although regulatory T (Treg) cells are vital for immune homeostasis and prevention of autoimmunity, they also exert an essential role in promoting tumor development. The mechanisms explaining why Treg cells remain functional in the hostile tumor microenvironment, while their effector counterparts become exhausted, remain incompletely understood. Here, we demonstrate that Treg-cell-specific deletion of Rbpj, the master transcription factor regulating Notch signaling, reduces tumor burden in mice. This is associated with the induction of an exhausted phenotype characterized by marked PD-1 upregulation. PD-1 deletion in Rbpj-deficient Treg cells reverses their exhausted phenotype and restores their tumor-promoting function. Finally, pharmacological inhibition of Rbpj using a novel small molecule promotes Treg cell exhaustion and reduces tumor growth. Collectively, our findings indicate that Notch-Rbpj signaling may act as an immune checkpoint pathway that hinders Treg exhaustion in tumors. The mechanisms explaining how the tumour microenvironment promotes regulatory T cell function, while rendering effector T cells exhausted, are incompletely understood. Here, the authors demonstrate that the transcription factor Rbpj, acts as checkpoint that prevents regulatory T cell exhaustion in tumours
Source: Nature Communications
Institutions: University of Crete, Academy of Athens, Biomedical Research Foundation of the Academy of Athens, National and Kapodistrian University of Athens, Technische Universität Dresden, Purdue University West Lafayette, FORTH Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas, University of Modena and Reggio Emilia
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $6,990
OpenAlex ID: W7225121064
